FarmavitaR+

1. Regulatory Updates - Free Webinar Series
(Regulatory Affairs/North America)

... regulatory updates (every 3 months) through an online webinar. These webinars are meant to keep you and all of your fellow coworkers up-to-date on the latest issues pertaining to scientific and regulatory ...

2. Russia’s Emerging OTC Market Holds Problems As Well As Promise
(Regulatory Affairs/Europe not-EU)

... - was No. 7 in the world in 2007, according to the World Bank's April 2009 ranking update. The U.K. was No. 6 and France was No. 8 during the period. The CIA data estimate Russia's population at 140 ...

3. Change of Access
(Regulatory Affairs/European Union)

... updated by the EC, such as: - Name of the medicinal product; - International Non-Proprietary Name (INN) of the active substance contained in the respective medicinal product; - Approved therapeutic ...

4. NMA of Romania News Flash
(Regulatory Affairs/European Union)

... need to be updated with respect to either of the above points, an appropriate variation application should be submitted. Marketing Authorisation Holders are requested to carry out the review of their ...

5. Bayer Schering Pharma AG
(Reports/Company Report)

... strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated ...

6. Wyeth
(Reports/Company Report)

... and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative ...

7. Johnson & Johnson
(Reports/Company Report)

... and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative ...

8. AstraZeneca plc
(Reports/Company Report)

... portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative ...

9. Schering-Plough Corporation
(Reports/Company Report)

... strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated ...

10. Amgen Inc.
(Reports/Company Report)

... and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative ...

11. Novo Nordisk A/S
(Reports/Company Report)

... portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative ...

12. Bristol-Myers Squibb Co.
(Reports/Company Report)

... strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated ...

13. Pfizer Inc.
(Reports/Company Report)

... and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative ...

14. Genentech Inc.
(Reports/Company Report)

... and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative ...

15. Chugai Pharmaceutical Co. Ltd
(Reports/Company Report)

... updated quantitative and qualitative information. Read more...  ...

16. Boehringer Ingelheim GmbH
(Reports/Company Report)

... strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated ...

17. Abbott Laboratories
(Reports/Company Report)

... strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated ...

18. Eli Lilly & Co.
(Reports/Company Report)

... portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative ...

19. GlaxoSmithKline
(Reports/Company Report)

... portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative ...

20. Update on e-CTD submission in Czech Republic
(Regulatory Affairs/European Union)

Update on e-CTD submission in Czech Republic „Special cases“ according to updated guideline REG-84- submission in eCTD format, released 02.10.2008. The following shall be considered special cases: ...